期刊文献+

抗抑郁新药——瑞美隆 被引量:3

暂未订购
导出
摘要 瑞美隆(Remeron)的国际通用名是米他扎品(Mirtazapine).其药理机制与以往的各类抗抑郁药不同,被称为Nassa(Noradrenergic and Specific Serotonergic Antidepressants,去甲肾上腺素和特异的五羟色胺抗抑郁药)。本文就该药的药理特性、临床疗效及不良反应作一概述。 1 药理特性 1.1 作用机制 瑞美隆的作用机制与以前我们所知的任何一种抗抑郁药均不相同,它同时作用于去甲肾上腺素神经和5-HT神经,促使去甲肾上腺素(NA)和5-HT的神经传导,起抗抑郁作用。神经生理学研究表明,瑞美隆通过三种途径起抗抑郁作用:(1)作用于脑去甲肾上腺素突触前膜α<sub>1</sub>自身受体,增加去甲肾上腺素神经冲动发放,促使NA释放,起部分抗抑郁作用。
出处 《上海医药》 CAS 1998年第6期31-32,共2页 Shanghai Medical & Pharmaceutical Journal
  • 相关文献

参考文献2

  • 1G. S. F. Ruigt,B. Kemp,C. M. Groenhout,H. A. C. Kamphuisen. Effect of the antidepressant Org 3770 on human sleep[J] 1990,European Journal of Clinical Pharmacology(6):551~554
  • 2P. Bech,P. Allerup,N. Reisby,L. F. Gram. Assessment of symptom change from improvement curves on the Hamilton depression scale in trials with antidepressants[J] 1984,Psychopharmacology(2):276~281

同被引文献24

  • 1李宗友.阔叶缬草的抗抑郁成分[J].国外医学:中医中药分册,1996,18(2):47-48.
  • 2Gorman J M. Mirtazapine : clinical overview . J Clin Psychiatry,1999,60 (suppl 17):9.
  • 3Roose S P. Tolerabitity and patient compliance. J Clin Psychiatry,1999,60 (suool 17):14.
  • 4Appelberg BG, Syvalafit EK ,Koshinen TE, et al. patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a place bo -controlled, randomized , double-blind, placebo wash-in study. J clin psychiatry,2001, 62 (6) :448.
  • 5Meijer W,Heerdink E,Leufkens H,et al.Incidence and determinants of long-term use of antidepressants[J].Eur J Clin Pharmacol,2004,60(1):57-61.
  • 6Moncrieff J,Wessely S,Hardy R.Active placebos versus antidepressants for depression[J].Cochrane Database Syst Rev,2004,(1):CD003012.
  • 7Alvarez W Jr,Pickworth KK.Pickworth kk Safety of antidepressant drugs in the patient with cardiac disease[J].Pharmacotherapy,2003,23(6):754-771.
  • 8Raymond CB,Morgan SG,Caetano PA.Antidepressant utilization in british columbia from 1996 to 2004:increasing prevalence but not incidence[J].Psychiatr Serv,2007,58(1):79-84.
  • 9Boyeson MG.Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiolegic patients undergoing rehabilitation therapy[J].Stroke,1996,27(11):2145-2146.
  • 10Linde K,Mulrow CD,Berner M,et al.St John's wort for depression[J].Cochrane Database Syst Rev,2005,(2):CD000448.

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部